John Schoen on Muck Rack

John Schoen

Verified
Sewell
As seen in: Healio, Infectious Diseases News, Anchorage Daily News, Healio Neurology, Healio Primary Care, Healio Women’s Health & OB/GYN, RealClear Markets, Citeline, The Bristol Bay Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with John

Contact John, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

American College of Physicians Internal Medicine Meeting

|
By John Schoen Verified, Gerald W. Smetana
| Healio Primary Care Verified
Key takeaways: All four novel drugs have been approved by the FDA last year. Cost could be a barrier to their use. SAN FRANCISCO — For the past 15 years, GeraldW.Smetana, MD, MACP, from Harvard Medical School, has given a presentation at the ACP Internal Medicine Meeting about new drugs that primary care physicians should be aware of.
Open in Who Shared Issue with article?

American College of Physicians Internal Medicine Meeting

|
By John Schoen Verified, Gerald W. Smetana, Mindy Valcarcel
| Citeline Verified
Key takeaways: All four novel drugs have been approved by the FDA last year. Cost could be a barrier to their use. SAN FRANCISCO — For the past 15 years, GeraldW.Smetana, MD, MACP, from Harvard Medical School, has given a presentation at the ACP Internal Medicine Meeting about new drugs that primary care physicians should be aware of.
Open in Who Shared Issue with article?

Psychedelics & Alternative Therapies

|
By Richard Gawel Verified, Stephanie Viguers Verified, John Schoen Verified
| Healio Verified
I certainly have concerns about any new treatment. My approach to any medication is to understand first on paper how it works: what’s the physiology, the mechanism, what is the science behind it? Then we really need to look at the harms, and have good clinical trials, to understand not only if it will work but also if it will be safe. So, my concerns with any new medication are what its safety profile is and if it will work the way we expect it to.
Open in Who Shared Issue with article?
See all 221 licensed articles (223 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified